Current research into retatritide peptide reveal notable possibility for managing obesity and non-insulin dependent disease. The peptide, a dual stimulator of glucagon-like peptide-1 and GIP, looks to offer enhanced weight loss and blood sugar control compared existing medications. Further clinical trials are needed to fully assess its safety histo